Sunshine Biopharma SBFM
NASDAQ SBFM
$0.67 -0.02 (-2.90%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sunshine Biopharma (SBFM) Non Operating Investment Income (2014 - 2025)

Updated

Sunshine Biopharma (SBFM) reported Non Operating Investment Income of -$7.00 for Q4 2025.

Analysis

Sunshine Biopharma (SBFM) Non Operating Investment Income (2014 - 2025) Analysis & Trends

For FY2025, Sunshine Biopharma posted Non Operating Investment Income of -$10,257.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Sunshine Biopharma 914,767.10 -38.18 Mn 2.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -7.00
Sep 30, 2025 -10,250.00
Jun 30, 2015 -513,155.00
Jun 30, 2014 -765,513.00
API Access

Sunshine Biopharma Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=SBFM&period=max&api_key=YOUR_API_KEY